Posted in | Nuclear Magnetic Resonance (NMR) Spectroscopy

Improving rapid narcotics analysis in the detection of illegal drugs

From Jul 18 2023

Detection of illegal drugs is an ongoing battle and the rapid analysis and identification of prohibited substances is critical to prevent their importation and widespread distribution. Additionally, the data generated needs to be significantly robust for submission in court cases. In most countries across the globe, a minimum of two orthogonal analytical methods must be used in drug testing to provide detailed and admissible evidence. Nuclear Magnetic Resonance and Mass Spectrometry are well established key methods for narcotics analysis, and operate on fundamentally different scientific principles, thus providing definitive identifications. Both methods validate each other and are now brought to your lab bench by Bruker. Today, Bruker’s powerful approach provides enhanced ease of use and maximized method compliance. Bruker supports leading law enforcement authorities worldwide. Become part of the community!

Speakers

Dr. Venita Decker

Product Manager FT-NMR benchtop solutions, BBIO, Bruker BioSpin, Rheinstetten, Germany

Dr. Venita Decker studied Neuroscience, but did her dissertation in the field of solid-state NMR (Max Planck Institute for Biophysical Chemistry, Goettingen). In 2012, she joined the Bruker solid-state NMR application. As a NMR-late entrant she since then actively supported Bruker solutions that simplify the complexity of NMR (TopSolids, the minispec FormCheck). Since 2018, she is the Product Manager for FT-NMR benchtop solutions, bringing her mission to the next level.

Dr. Joerg Koehler

Head of Business Unit Industrial, Bruker BioSpin, Rheinstetten, Germany

Dr. Joerg Koehler studied physics and holds a doctoral degree from the Institute of Biophysics and Physical Biochemistry of the University of Regensburg. After several positions in sales, sales management, and business administration he joined Bruker as Head of Business Unit Industrial. Today Dr. Joerg Koehler is accountable for Bruker’s global activities in magnetic resonance in various industrial market segments including forensics.

Dr. Andrea Kiehne

Head of Bremen applied solutions demo team, Bruker Daltonik, Bremen

Dr. Andrea Kiehne is a highly experienced mass spectrometrist with over 20 years’ experience of applying nominal mass, accurate mass and trapped ion mobility MS systems to the analysis of complex matrices including forensic samples. She joined Bruker in 1998 having completed her PhD in Food Chemistry at the University of Braunschweig, Germany followed by a Post-Doctoral position also at the University of Braunschweig. Currently she is Head of Bruker’s applied solutions demo team at our Bremen facility.

Key learning objectives

  • Increase evidence robustness by application of orthogonal methods
  • Take advantage of training and maintenance synergies from one single point of contact
  • Enhance ease of use and through put with harmonized methods
  • Shorten time to result with benchtop instruments in every local laboratory

Who should attend?

This webinar will be of interest to those working in forensic laboratories, law enforcement authorities, customs & border protection agencies, regulatory bodies, official control laboratories and undertaking analysis of narcotics or suspected narcotics.

View the recording or download the slides

Other Webinars from Bruker BioSpin - NMR, EPR and Imaging

Dynamic Nuclear Polarization in the study of pharmaceuticals

Dynamic Nuclear Polarization in the study of pharmaceuticals
Potency Determination by qNMR

Potency Determination by qNMR
High speed spectroscopy – New AVANCE NEO

High speed spectroscopy – New AVANCE NEO
Is it really pure honey? Detecting adulterations, frauds and quality issues by NMR-based Honey-Profiling

Is it really pure honey? Detecting adulterations, frauds and quality issues by NMR-based Honey-Profiling
Solid State NMR Made Easy

Solid State NMR Made Easy
In Vivo Tumor Progression Studies: The Relative Strengths of Available Imaging Modalities and Reporter Constructs

In Vivo Tumor Progression Studies: The Relative Strengths of Available Imaging Modalities and Reporter Constructs
Studying Cancer biology and Therapeutic Targets Using PET Technology: Opening an Extraordinary Option

Studying Cancer biology and Therapeutic Targets Using PET Technology: Opening an Extraordinary Option
Automatizing the qualitative and quantitative analysis of complex drugs using NMR

Automatizing the qualitative and quantitative analysis of complex drugs using NMR
Imaging of Infection and Tumors using labelled Siderophores

Imaging of Infection and Tumors using labelled Siderophores
Metabolic Imaging in Neurodegenerative Disease using CEST MRI

Metabolic Imaging in Neurodegenerative Disease using CEST MRI
In vivo Magnetic Resonance Imaging

In vivo Magnetic Resonance Imaging
NMR-based fragment screening for drug discovery

NMR-based fragment screening for drug discovery
Pharmaceutical Applications of Electron Paramagnetic Resonance (EPR) Spectroscopy

Pharmaceutical Applications of Electron Paramagnetic Resonance (EPR) Spectroscopy
Improving Mechanistic Understanding of Fast Reactions Using Rapid, Reproducible In Situ Analysis by Stop-Flow NMR and IR

Improving Mechanistic Understanding of Fast Reactions Using Rapid, Reproducible In Situ Analysis by Stop-Flow NMR and IR
A Universal MicroCT Analysis Pipeline for Bone Preclinical Disease Models

A Universal MicroCT Analysis Pipeline for Bone Preclinical Disease Models
EPR as a Teaching Tool in the Laboratory

EPR as a Teaching Tool in the Laboratory
How microCT Can Provide Insight into Dynamic Disease Processes

How microCT Can Provide Insight into Dynamic Disease Processes
Solid Form Quantification – A New Benchtop Solution

Solid Form Quantification – A New Benchtop Solution
Webinar Overview: EPR as a Teaching Tool in the Laboratory

Webinar Overview: EPR as a Teaching Tool in the Laboratory
Intelligent Use of NMR for Synthetic Organic Chemistry

Intelligent Use of NMR for Synthetic Organic Chemistry
Early Disease Detection Performing NMR

Early Disease Detection Performing NMR
Using Micro-CT Imaging for the Phenotyping and Analysis of Bone Architecture

Using Micro-CT Imaging for the Phenotyping and Analysis of Bone Architecture
Using High Fields to Combat Ischemic Stroke with Cell Therapy

Using High Fields to Combat Ischemic Stroke with Cell Therapy
Endodontic Applications of Microcomputed Tomography for Studying Root Canals

Endodontic Applications of Microcomputed Tomography for Studying Root Canals
Studying Cardiovascular Pathology with MRI

Studying Cardiovascular Pathology with MRI
Improved Open-Access NMR for the Synthetic and Analytical Chemistry Laboratories

Improved Open-Access NMR for the Synthetic and Analytical Chemistry Laboratories
DTI Connectomics in Mouse Models of Neurological Disorders

DTI Connectomics in Mouse Models of Neurological Disorders
Monitoring Cancer Treatments with Immuno-PET

Monitoring Cancer Treatments with Immuno-PET
Early Detection of Metabolic Remodeling in Pressure Overload Left Ventricle Hypertrophy Using Dynamic PET Imaging

Early Detection of Metabolic Remodeling in Pressure Overload Left Ventricle Hypertrophy Using Dynamic PET Imaging
Introducing the Next Revolution in EPR, the Rapid Scan Accessory

Introducing the Next Revolution in EPR, the Rapid Scan Accessory
MicroCT Applications in Lung Research and Immunology

MicroCT Applications in Lung Research and Immunology
Micro-CT in 3D Data Integration and (Clinical) Workflows for Digital Orthodontics

Micro-CT in 3D Data Integration and (Clinical) Workflows for Digital Orthodontics
Ex Vivo MicroangioCT: Advances in Microvascular Imaging

Ex Vivo MicroangioCT: Advances in Microvascular Imaging
Treatments of COVID-19: Old Drugs, New Tricks

Treatments of COVID-19: Old Drugs, New Tricks
NMR Characterization of Polysaccharide-Based Vaccines

NMR Characterization of Polysaccharide-Based Vaccines
Hyperpolarized Xe MRI of Pulmonary Gas-Exchange in Rodents

Hyperpolarized Xe MRI of Pulmonary Gas-Exchange in Rodents
PET Image Reconstruction Overview - Current and Future Trends

PET Image Reconstruction Overview - Current and Future Trends
Unlocking your clinical understanding of Post-Acute COVID Syndrome (PACS), patient recover, and risk of subsequent disease

Unlocking your clinical understanding of Post-Acute COVID Syndrome (PACS), patient recover, and risk of subsequent disease
New Psychoactive Substances (NPS): automated identification and quantification

New Psychoactive Substances (NPS): automated identification and quantification
Present and future of human metabolomics (for research use only)

Present and future of human metabolomics (for research use only)
NMR based lipoprotein phenotyping can reveal recovery subgroups in SARS-CoV 2 infected patients

NMR based lipoprotein phenotyping can reveal recovery subgroups in SARS-CoV 2 infected patients
How to easily automate chemical mixture analysis

How to easily automate chemical mixture analysis
Evolving your biobank business model

Evolving your biobank business model
PET/MR imaging to study liver diseases

PET/MR imaging to study liver diseases
How to Validate and Implement qNMR as a Platform Method for Oligonucleotides

How to Validate and Implement qNMR as a Platform Method for Oligonucleotides
Advanced PET/MRI Techniques for Characterizing Hypoxic Breast Cancer Tumors

Advanced PET/MRI Techniques for Characterizing Hypoxic Breast Cancer Tumors
The role of lipoproteins in inflammatory response

The role of lipoproteins in inflammatory response

Life Science Webinars by Subject Matter

Watch the
Webinar

More Articles from
Bruker BioSpin - NMR, EPR and Imaging

More Products from
Bruker BioSpin - NMR, EPR and Imaging

See all content from Bruker BioSpin - NMR, EPR and Imaging
Watch the
Webinar

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback